These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24535283)

  • 21. Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis.
    Matye DJ; Wang H; Luo W; Sharp RR; Chen C; Gu L; Jones KL; Ding WX; Friedman JE; Li T
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):1001-1019. PubMed ID: 33965587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis.
    Ji S; Liu Q; Zhang S; Chen Q; Wang C; Zhang W; Xiao C; Li Y; Nian C; Li J; Li J; Geng J; Hong L; Xie C; He Y; Chen X; Li X; Yin ZY; You H; Lin KH; Wu Q; Yu C; Johnson RL; Wang L; Chen L; Wang F; Zhou D
    Dev Cell; 2019 Feb; 48(4):460-474.e9. PubMed ID: 30745141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast Growth Factor 15-Dependent and Bile Acid-Independent Promotion of Liver Regeneration in Mice.
    Kong B; Sun R; Huang M; Chow MD; Zhong XB; Xie W; Lee YH; Guo GL
    Hepatology; 2018 Nov; 68(5):1961-1976. PubMed ID: 29672888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
    Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
    FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling.
    Yan S; Khambu B; Chen X; Dong Z; Guo G; Yin XM
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):973-997. PubMed ID: 33127558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.
    Alvarez-Sola G; Uriarte I; Latasa MU; Jimenez M; Barcena-Varela M; Santamaría E; Urtasun R; Rodriguez-Ortigosa C; Prieto J; Berraondo P; Fernandez-Barrena MG; Berasain C; Avila MA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1326-1334. PubMed ID: 28709961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiology of FGF15/19.
    Jones SA
    Adv Exp Med Biol; 2012; 728():171-82. PubMed ID: 22396169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers.
    Naugler WE; Tarlow BD; Fedorov LM; Taylor M; Pelz C; Li B; Darnell J; Grompe M
    Gastroenterology; 2015 Sep; 149(3):728-40.e15. PubMed ID: 26028580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
    Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
    J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
    J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enterohepatic bacterial infections dysregulate the FGF15-FGFR4 endocrine axis.
    Romain G; Tremblay S; Arena ET; Antunes LC; Covey S; Chow MT; Finlay BB; Menendez A
    BMC Microbiol; 2013 Oct; 13():238. PubMed ID: 24165751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance.
    Bozadjieva-Kramer N; Shin JH; Li Z; Rupp AC; Miller N; Kernodle S; Lanthier N; Henry P; Seshadri N; Myronovych A; MacDougald OA; O'Rourke RW; Kohli R; Burant CF; Rothberg AE; Seeley RJ
    JCI Insight; 2024 Apr; 9(7):. PubMed ID: 38587078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy.
    Chow MD; Otersen K; Wassef A; Kong B; Yamarthy S; Rizzolo D; Yang I; Buckley B; Lu A; Crook N; Lee M; Gao J; Naganand S; Stofan MF; Armstrong L; Schumacher J; Taylor R; Henry Z; Basaly V; Yang Z; Zhang M; Huang M; Kagan L; Brunetti L; Sadek R; Lee YH; Guo GL
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes.
    Rizzolo D; Kong B; Piekos S; Chen L; Zhong X; Lu J; Shi J; Zhu HJ; Yang Q; Li A; Li L; Wang H; Siemiątkowska A; Park C; Kagan L; Guo GL
    Drug Metab Dispos; 2022 Apr; 50(4):468-477. PubMed ID: 34965924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice.
    Li Q; Zhao Q; Zhang C; Zhang P; Hu A; Zhang L; Schroder PM; Ma Y; Guo Z; Zhu X; He X
    J Physiol Biochem; 2018 May; 74(2):247-260. PubMed ID: 29468415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
    Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
    Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polygonum multiflorum Thunb suppress bile acid synthesis by activating Fxr-Fgf15 signaling in the intestine.
    Wei J; Chen J; Fu L; Han L; Gao X; Sarhene M; Hu L; Zhang Y; Fan G
    J Ethnopharmacol; 2019 May; 235():472-480. PubMed ID: 30528660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile acids as metabolic regulators.
    Li T; Chiang JY
    Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.